She worked at the Department of Paediatric Infectious Diseases at the School of Medicine of Emory University of Atlanta, USA (2013) as a postdoctoral fellow. Using high throughput screening strategy combined to cell-based assay development, she discovered and characterized new HIV-1 and Ebola virus entry inhibitors for HIV-1 and Ebola virus entry. She started in the assay development and screening team in May 2017.
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function
Fagan V. et al, (2019), Journal of Medicinal Chemistry
Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Christott T. et al, (2018), SLAS Discov
Development of a YEATS-domain chemical probe
Moustakim M. et al, (2018), ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 256
Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors
GIROUD None. et al, (2017), ASSAY and Drug Development Technologies, 15, 53 - 63
P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C. et al, (2015), J Virol, 89, 9368 - 9382